Status:
COMPLETED
Hyperglycemia in Patients With Takotsubo Syndrome
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Takotsubo Cardiomyopathy
Eligibility:
All Genders
18-75 years
Brief Summary
Patients with Takotsubo cardiomiopathy (TTC) have over-inflammation and over-sympathetic tone. However, these conditions could cause higher rate of heart failure (HF) events and deaths at 2 years of f...
Eligibility Criteria
Inclusion
- acute onset of a cardiovascular event, usually associated with substernal chest pain, initially regarded as STEMI/evolving coronary syndrome;
- cardiac biomarker modifications (creatine kinase-MB and troponin I);
- systolic dysfunction, predominantly characterized by akinesia/hypokinesia of the mid-to-distal portion of the left ventricle (LV) chamber, with hyper-contractile basal LV.
Exclusion
- patients with previous previous myocardial infarction;
- patients with previous TTC event;
- patients affected by chronic kidney, liver, and cerebrovascular diseases.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04684004
Start Date
January 1 2013
End Date
January 1 2019
Last Update
December 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Raffaele Marfella
Naples, Italy, 80138